JAIME HOLTHAUS: Open Payments
NPI 1194210070 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,609 in 126 payments from 20 companies in 2025. Trend: 2023 $1,191 · 2024 $2,090 · 2025 $2,609
Food & beverage: $2,524Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $559 |
| AstraZeneca Pharmaceuticals LP | 7 | $278 |
| PFIZER INC. | 20 | $278 |
| Novo Nordisk Inc | 11 | $264 |
| Verona Pharma, Inc. | 9 | $201 |
| Dexcom, Inc. | 3 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $139 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Astellas Pharma US Inc | 2 | $102 |
| Amgen Inc. | 6 | $98 |
Products named: QULIPTA, NURTEC ODT, Ohtuvayre, Ozempic, FARXIGA, DEXCOM G7 GSS (161), Kerendia, UBRELVY.
Industry payments across AR — which companies pay providers there.
